Welcome to ClearClinica
TRY DEMO
LOGIN
ARTICLES

CE MARK GRANTED TO NUCLEIX’S BLADDER EPICHECK FOR BLADDER CANCER MONITORING

Posted by Danny Lieberman on Apr 28, 2017 2:28:38 PM

Clear Clinica customer Nucleix is running a large-scale multi-center study using the Clear Clinica managed Clinical cloud - which includes cloud EDC and the Clear Clinica monitoring as a service real time alerts and analytics that visualize...

Read More

Celator Pharmaceuticals Announces Vyxeos Granted Breakthrough Therapy Designation

Posted by Drugs.com on Jun 23, 2016 2:08:08 PM

EWING, N.J., May 19, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) announced that the United States Food and Drug Administration (FDA) granted Breakthrough Therapy designation to Vyxeos (also known as CPX-351). Vyxeos is an...

Read More

Nearly all drug trials scientifically invalid due to influence of the mind; Big Pharma science dissolves into wishful thinking

Posted by Mike Adams on Jun 22, 2016 2:16:22 PM

(NaturalNews) A new study in Science Translational Medicine has cast doubt over the scientific validity of nearly all randomized, double-blind placebo controlled studies involving pharmaceuticals used on human beings. It turns out that many...

Read More

Acetaminophen 'an ineffective treatment for osteoarthritis'

Posted by Honor Whiteman on Jun 22, 2016 2:05:01 PM

Taken alone, acetaminophen is "not effective at any dose" for relieving pain or improving physical function for patients with osteoarthritis, concludes a large-scale meta-analysis recently published inThe Lancet

 

Dr. Sven Trelle, of the...

Read More

Surgeons trial new drug to help brain haemorrhage patients

Posted by Medical News Today on Jun 22, 2016 1:58:53 PM

Surgeons in Southampton are trialling a new drug based on a chemical found in broccoli to try to improve outcomes for brain haemorrhage patients.

 

Diederik Bulters, a consultant neurosurgeon at Southampton General Hospital, and his team will...

Read More

Clinical trial underway for treatment of sleep apnea in adolescents with Down syndrome

Posted by Medical News Today on Jun 22, 2016 1:41:08 PM

 

 

New technology may benefit unique population of patients who cannot tolerate CPAP machines.

 

An FDA-approved clinical trial is underway at Massachusetts Eye and Ear and Massachusetts General Hospital for Children to evaluate the use of a...

Read More

Ebola vaccine: Promising phase I trials

Posted by Medical News Today on Jun 22, 2016 1:26:09 PM

 

"The results for tolerability, safety, and the immune response to the vaccine candidate are very promising," explains Prof Marylyn Addo. The antibodies which developed against the virus were still detectable after six months. Addo is convinced,...

Read More

Alizé Pharma reports positive results from its Phase II clinical trial of AZP-531 in Prader-Willi Syndrome

Posted by Medical News Today on Jun 22, 2016 1:17:46 PM

 

 

Results from the randomized, double blind and placebo-controlled Phase II trial show significant improvements in hyperphagia-related behavior, a key therapeutic objective in Prader-Willi Syndrome.

 

Alizé Pharma SAS, an Alizé Pharma group...

Read More

New data shows benefits of Medtronic insulin pumps for people with type 2 diabetes

Posted by Medical News Today on Jun 22, 2016 12:54:04 PM

Medtronic plc has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise study, providing further clinical evidence in support of insulin pumps for people with insulin-requiring type...

Read More

GW Pharmaceuticals initiates Phase 3 pivotal study in Tuberous Sclerosis Complex

Posted by Medical News Today on Jun 22, 2016 12:27:53 PM

GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, has announced that it has commenced a Phase 3 clinical trial of...

Read More